| molecular function |
| | GO:0048020 | | CCR chemokine receptor binding | | Interacting selectively and non-covalently with a CCR chemokine receptor. |
| | GO:0031732 | | CCR7 chemokine receptor binding | | Interacting selectively and non-covalently with a CCR7 chemokine receptor. |
| | GO:0008009 | | chemokine activity | | The function of a family of small chemotactic cytokines; their name is derived from their ability to induce directed chemotaxis in nearby responsive cells. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria. |
| | GO:0042379 | | chemokine receptor binding | | Interacting selectively and non-covalently with any chemokine receptor. |
| | GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| biological process |
| | GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| | GO:0031295 | | T cell costimulation | | The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation. |
| | GO:0090630 | | activation of GTPase activity | | Any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP. |
| | GO:0060326 | | cell chemotaxis | | The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| | GO:0048469 | | cell maturation | | A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state. |
| | GO:0007267 | | cell-cell signaling | | Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions. |
| | GO:0071346 | | cellular response to interferon-gamma | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far. |
| | GO:0071347 | | cellular response to interleukin-1 | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
| | GO:0071356 | | cellular response to tumor necrosis factor | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. |
| | GO:0070098 | | chemokine-mediated signaling pathway | | A series of molecular signals initiated by the binding of a chemokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0006935 | | chemotaxis | | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| | GO:0002407 | | dendritic cell chemotaxis | | The movement of a dendritic cell in response to an external stimulus. |
| | GO:0097026 | | dendritic cell dendrite assembly | | Formation of dendrites, branched cellular projections (or cytoplasmic extension) that are extended from the surface of a dendritic immune cell, and which enable the cell to sample luminal pathogens and increase the surface area for antigen presentation to T cells. |
| | GO:0001768 | | establishment of T cell polarity | | The directed orientation of T cell signaling molecules and associated membrane rafts towards a chemokine gradient or a contact point with antigen presenting cell. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0001771 | | immunological synapse formation | | The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction. |
| | GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| | GO:0048247 | | lymphocyte chemotaxis | | The directed movement of a lymphocyte in response to an external stimulus. |
| | GO:0035759 | | mesangial cell-matrix adhesion | | The binding of a mesangial cell to the extracellular matrix via adhesion molecules. A mesangial cell is a cell that encapsulates the capillaries and venules in the kidney. |
| | GO:0002548 | | monocyte chemotaxis | | The movement of a monocyte in response to an external stimulus. |
| | GO:2000548 | | negative regulation of dendritic cell dendrite assembly | | Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell dendrite assembly. |
| | GO:2000107 | | negative regulation of leukocyte apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte apoptotic process. |
| | GO:1903237 | | negative regulation of leukocyte tethering or rolling | | Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte tethering or rolling. |
| | GO:0070374 | | positive regulation of ERK1 and ERK2 cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| | GO:0043123 | | positive regulation of I-kappaB kinase/NF-kappaB signaling | | Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. |
| | GO:0046330 | | positive regulation of JNK cascade | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
| | GO:2000406 | | positive regulation of T cell migration | | Any process that activates or increases the frequency, rate or extent of T cell migration. |
| | GO:0030838 | | positive regulation of actin filament polymerization | | Any process that activates or increases the frequency, rate or extent of actin polymerization. |
| | GO:0033630 | | positive regulation of cell adhesion mediated by integrin | | Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin. |
| | GO:2000147 | | positive regulation of cell motility | | Any process that activates or increases the frequency, rate or extent of cell motility. |
| | GO:0001954 | | positive regulation of cell-matrix adhesion | | Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix. |
| | GO:0050921 | | positive regulation of chemotaxis | | Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient. |
| | GO:0002606 | | positive regulation of dendritic cell antigen processing and presentation | | Any process that activates or increases the frequency, rate, or extent of dendritic cell antigen processing and presentation. |
| | GO:0051491 | | positive regulation of filopodium assembly | | Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone. |
| | GO:0010560 | | positive regulation of glycoprotein biosynthetic process | | Any process that increases the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of glycoproteins, any protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide. |
| | GO:2000529 | | positive regulation of myeloid dendritic cell chemotaxis | | Any process that activates or increases the frequency, rate or extent of myeloid dendritic cell chemotaxis. |
| | GO:0090023 | | positive regulation of neutrophil chemotaxis | | Any process that increases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
| | GO:0043552 | | positive regulation of phosphatidylinositol 3-kinase activity | | Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity. |
| | GO:0051897 | | positive regulation of protein kinase B signaling | | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
| | GO:0045860 | | positive regulation of protein kinase activity | | Any process that activates or increases the frequency, rate or extent of protein kinase activity. |
| | GO:0031274 | | positive regulation of pseudopodium assembly | | Any process that activates or increases the frequency, rate or extent of the assembly of pseudopodia. |
| | GO:0048260 | | positive regulation of receptor-mediated endocytosis | | Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. |
| | GO:0051209 | | release of sequestered calcium ion into cytosol | | The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the cytosolic compartment. |
| | GO:0034695 | | response to prostaglandin E | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus. |
| | GO:0031529 | | ruffle organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a ruffle, a projection at the leading edge of a crawling cell. |
| cellular component |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005622 | | intracellular | | The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |